Liberty Health Sciences Responds to Short-Seller Report

TORONTO, Dec. 6, 2018 /CNW/ – Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF)  (“Liberty” or the “Company”), a provider of high quality cannabis, is aware of a short-seller report (the “Report”) attempting to manipulate Liberty’s share price through a series of unconfirmed allegations.

The Report contains a number of factual errors and outdated information. As cited in the Report’s disclaimers, its authors stand to benefit financially by manipulating Liberty’s stock. Investors should exercise caution in relying on the statements contained in this Report. Liberty takes the unconfirmed allegations contained in the Report very seriously and will provide updates as they relate to this matter in due course. Liberty is committed to good corporate governance and transparency.

About Liberty Health Sciences Inc.

Liberty is the cannabis provider committed to providing a trusted, high quality cannabis experience based on our genuine care for all cannabis users and a focus on operational excellence from seed to sale and beyond. Liberty’s measured approach to expansion opportunities maximizes returns to shareholders, while keeping consumers’ well-being at the forefront of what we do. For more information, please visit: www.libertyhealthsciences.com.

Original press release

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter